Report Detail
Global RNAi for Therapeutic Market Growth (Status and Outlook) 2019-2024
- RnM2946923 |
- 15 February, 2019 |
- Global |
- 138 Pages |
- LPI(LP Information) |
- Other
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
RNAi for Therapeutic is in the development stage and there is no use in the market. The fastest research is Clinical phrase III, Such as QP1-1007, QO1-1002 of Quark Pharmaceuticals. The major technology of RNAi for Therapeutic is siRNA, miRNA and shRNA. SiRNA technology is the most popular, with the expenses market share of 85%, following SiRNA, miRNA is the second of 16% expenses market share in 2015.
At present, global expenses concentrates in US and Europe, US takes 80% market share and Europe takes 5% market share. There is A Few R & D Company in the world and the market concentration is high. The top5 (expenses in RNAi for Therapeutic) companies are Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Gradalis, miRagen Therapeutics. The five companies occupy about 83% of the market share.
According to this study, over the next five years the RNAi for Therapeutic market will register a 24.0% CAGR in terms of revenue, the global market size will reach US$ 3580 million by 2024, from US$ 990 million in 2019. In particular, this report presents the global revenue market share of key companies in RNAi for Therapeutic business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of RNAi for Therapeutic market by product type, application, key companies and key regions.
This study considers the RNAi for Therapeutic value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
siRNA
miRNA
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Cancer
Cardiovascular
HBV
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global RNAi for Therapeutic market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of RNAi for Therapeutic market by identifying its various subsegments.
Focuses on the key global RNAi for Therapeutic players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the RNAi for Therapeutic with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of RNAi for Therapeutic submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global RNAi for Therapeutic Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global RNAi for Therapeutic Market Size 2014-2024
- 2.1.2 RNAi for Therapeutic Market Size CAGR by Region
- 2.2 RNAi for Therapeutic Segment by Type
- 2.2.1 siRNA
- 2.2.2 miRNA
- 2.2.3 shRNA
- 2.3 RNAi for Therapeutic Market Size by Type
- 2.3.1 Global RNAi for Therapeutic Market Size Market Share by Type (2014-2019)
- 2.3.2 Global RNAi for Therapeutic Market Size Growth Rate by Type (2014-2019)
- 2.4 RNAi for Therapeutic Segment by Application
- 2.4.1 Cancer
- 2.4.2 Cardiovascular
- 2.4.3 HBV
- 2.4.4 Other
- 2.5 RNAi for Therapeutic Market Size by Application
- 2.5.1 Global RNAi for Therapeutic Market Size Market Share by Application (2014-2019)
- 2.5.2 Global RNAi for Therapeutic Market Size Growth Rate by Application (2014-2019)
3 Global RNAi for Therapeutic by Players
- 3.1 Global RNAi for Therapeutic Market Size Market Share by Players
- 3.1.1 Global RNAi for Therapeutic Market Size by Players (2017-2019)
- 3.1.2 Global RNAi for Therapeutic Market Size Market Share by Players (2017-2019)
- 3.2 Global RNAi for Therapeutic Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 RNAi for Therapeutic by Regions
- 4.1 RNAi for Therapeutic Market Size by Regions
- 4.2 Americas RNAi for Therapeutic Market Size Growth
- 4.3 APAC RNAi for Therapeutic Market Size Growth
- 4.4 Europe RNAi for Therapeutic Market Size Growth
- 4.5 Middle East & Africa RNAi for Therapeutic Market Size Growth
5 Americas
- 5.1 Americas RNAi for Therapeutic Market Size by Countries
- 5.2 Americas RNAi for Therapeutic Market Size by Type
- 5.3 Americas RNAi for Therapeutic Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC RNAi for Therapeutic Market Size by Countries
- 6.2 APAC RNAi for Therapeutic Market Size by Type
- 6.3 APAC RNAi for Therapeutic Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe RNAi for Therapeutic by Countries
- 7.2 Europe RNAi for Therapeutic Market Size by Type
- 7.3 Europe RNAi for Therapeutic Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa RNAi for Therapeutic by Countries
- 8.2 Middle East & Africa RNAi for Therapeutic Market Size by Type
- 8.3 Middle East & Africa RNAi for Therapeutic Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global RNAi for Therapeutic Market Forecast
- 10.1 Global RNAi for Therapeutic Market Size Forecast (2019-2024)
- 10.2 Global RNAi for Therapeutic Forecast by Regions
- 10.2.1 Global RNAi for Therapeutic Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global RNAi for Therapeutic Forecast by Type
- 10.8 Global RNAi for Therapeutic Forecast by Application
11 Key Players Analysis
- 11.1 Alnylam Pharmaceuticals
- 11.1.1 Company Details
- 11.1.2 RNAi for Therapeutic Product Offered
- 11.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Alnylam Pharmaceuticals News
- 11.2 Arbutus Biopharma (Tekmira)
- 11.2.1 Company Details
- 11.2.2 RNAi for Therapeutic Product Offered
- 11.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Arbutus Biopharma (Tekmira) News
- 11.3 Arrowhead
- 11.3.1 Company Details
- 11.3.2 RNAi for Therapeutic Product Offered
- 11.3.3 Arrowhead RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Arrowhead News
- 11.4 Dicerna Pharmaceuticals
- 11.4.1 Company Details
- 11.4.2 RNAi for Therapeutic Product Offered
- 11.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Dicerna Pharmaceuticals News
- 11.5 Mirna Therapeutics
- 11.5.1 Company Details
- 11.5.2 RNAi for Therapeutic Product Offered
- 11.5.3 Mirna Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Mirna Therapeutics News
- 11.6 Quark Pharmaceuticals
- 11.6.1 Company Details
- 11.6.2 RNAi for Therapeutic Product Offered
- 11.6.3 Quark Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Quark Pharmaceuticals News
- 11.7 RXi Pharmaceuticals
- 11.7.1 Company Details
- 11.7.2 RNAi for Therapeutic Product Offered
- 11.7.3 RXi Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 RXi Pharmaceuticals News
- 11.8 Silence Therapeutics
- 11.8.1 Company Details
- 11.8.2 RNAi for Therapeutic Product Offered
- 11.8.3 Silence Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Silence Therapeutics News
- 11.9 Benitec Biopharma
- 11.9.1 Company Details
- 11.9.2 RNAi for Therapeutic Product Offered
- 11.9.3 Benitec Biopharma RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Benitec Biopharma News
- 11.10 miRagen Therapeutics
- 11.10.1 Company Details
- 11.10.2 RNAi for Therapeutic Product Offered
- 11.10.3 miRagen Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 miRagen Therapeutics News
- 11.11 Sylentis
- 11.12 Gradalis
- 11.13 Sirnaomics
- 11.14 Silenseed
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on RNAi for Therapeutic . Industry analysis & Market Report on RNAi for Therapeutic is a syndicated market report, published as Global RNAi for Therapeutic Market Growth (Status and Outlook) 2019-2024
. It is complete Research Study and Industry Analysis of RNAi for Therapeutic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
